Home
>
National Drug Code (NDC)
>
Amoxicillin and Clavulanate Potassium
Amoxicillin and Clavulanate Potassium - 43598-220-28 - (amoxicillin and clavulanate potassium)
Drug Information of Amoxicillin and Clavulanate Potassium
| Product NDC: | 43598-220 |
| Proprietary Name: | Amoxicillin and Clavulanate Potassium |
| Non Proprietary Name: | amoxicillin and clavulanate potassium |
| Active Ingredient(s): | 562.5; 437.5; 62.5 mg/1; mg/1; mg/1 & nbsp; amoxicillin and clavulanate potassium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Amoxicillin and Clavulanate Potassium
| Product NDC: | 43598-220 |
| Labeler Name: | Dr Reddys Laboratories Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050785 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030911 |
Package Information of Amoxicillin and Clavulanate Potassium
| Package NDC: | 43598-220-28 |
| Package Description: | 28 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43598-220-28) |
NDC Information of Amoxicillin and Clavulanate Potassium
| NDC Code | 43598-220-28 |
| Proprietary Name | Amoxicillin and Clavulanate Potassium |
| Package Description | 28 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43598-220-28) |
| Product NDC | 43598-220 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | amoxicillin and clavulanate potassium |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20030911 |
| Marketing Category Name | NDA |
| Labeler Name | Dr Reddys Laboratories Inc |
| Substance Name | AMOXICILLIN; AMOXICILLIN SODIUM; CLAVULANATE POTASSIUM |
| Strength Number | 562.5; 437.5; 62.5 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |
